CNNModerna coronavirus vaccine shows 'promising' safety and immune response results in published Phase 1 study, but more research is neededJul 15, 2020John Bonifield & Jacqueline HowardBy John Bonifield & Jacqueline Howardmore_vert
Investor's Business DailyIs Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?6 days agoAllison GatlinBy Allison Gatlinmore_vert
National Institutes of Health (NIH) (.gov)Experimental COVID-19 vaccine safe, generates immune responseJul 14, 2020more_vert
Smithsonian MagazineWhat Are mRNA Vaccines, and Could They Work Against COVID-19?Jul 16, 2020more_vert
The New York TimesFirst Coronavirus Vaccine Tested in Humans Shows Early Promise (Published 2020)Jul 30, 2020Denise GradyBy Denise Gradymore_vert
BloombergOxford’s Covid-19 Vaccine Is the Coronavirus Front-RunnerJul 15, 2020Stephanie BakerBy Stephanie Bakermore_vert
Clinical Trials ArenaChina's Sinopharm launches Phase III trial of Covid-19 vaccine in UAEJul 17, 2020Divya TirumalarajuBy Divya Tirumalarajumore_vert
Emory News CenterCOVID-19 vaccine tested at Emory is safe, generates immune response, early results showJul 14, 2020more_vert
STATFirst data for Moderna Covid-19 vaccine show it spurs an immune responseJul 14, 2020Matthew Herper & Damian GardeBy Matthew Herper & Damian Gardemore_vert
NBC NewsCOVID-19 vaccine: Promising results from Moderna's first trial as they aim to start final phaseJul 14, 2020Erika Edwards & Sara G. MillerBy Erika Edwards & Sara G. Millermore_vert